ACSL5 antibody
Principal name
ACSL5 antibody
Alternative names for ACSL5 antibody
ACS5, FACL5, LACS5, Long-chain-fatty-acid--CoA ligase 5, Long-chain acyl-CoA synthetase 5
Ncbi ID
9606, NP_057318.2, NP_976313, NM_203379, NM_203380, NM_016234, NP_976314, NP_082252.1, NM_027976
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), Western blot / Immunoblot (WB), Paraffin Sections (P), ELISA (detection) (E(detection)), EPair for Elisa (EPair), Immunoprecipitation (IP)
Background of ACSL5 antibody
- Kit Component:
- - KN300760G1, Acsl5 gRNA vector 1 in pCas-Guide vector
- KN300760G2, Acsl5 gRNA vector 2 in pCas-Guide vector
- KN300760D, donor vector containing left and right homologous arms and Luciferase-Puro functional cassette
- GE100003, scramble sequence in pCas-Guide vector - CRISPR Manual:
- CRISPR/CAS9 Genome Editing Manual
Immunoperoxidase of monoclonal antibody to ACSL5 on formalin-fixed paraffin-embedded human colon. [antibody concentration 3 ug/ml]
Western Blot analysis of ACSL5 expression in transfected 293T cell line by ACSL5 monoclonal antibody (M01), clone 5H8.Lane 1: ACSL5 transfected lysate(82.3 KDa).Lane 2: Non-transfected lysate.
ACSL5 monoclonal antibody (M01), clone 5H8 Western Blot analysis of ACSL5 expression in HepG2 ( Cat # L019V1 ).
Detection limit for recombinant GST tagged ACSL5 is approximately 0.1ng/ml as a capture antibody.
ACSL5 polyclonal antibody ( Cat # PAB7030 ) ( 1 µg/ml ) staining of human spleen lysate ( 35 µg protein in RIPA buffer ) . Primary incubation was 1 hour. Detected by chemiluminescence.
ACSL5 MaxPab polyclonal antibody. Western Blot analysis of ACSL5 expression in human liver.
Western Blot analysis of ACSL5 expression in transfected 293T cell line (H00051703-T01) by ACSL5 MaxPab polyclonal antibody.Lane 1: ACSL5 transfected lysate(81.29 KDa).Lane 2: Non-transfected lysate.
Western Blot analysis of ACSL5 expression in transfected 293T cell line (H00051703-T01) by ACSL5 MaxPab polyclonal antibody.Lane 1: ACSL5 transfected lysate(82.30 KDa).Lane 2: Non-transfected lysate.
Small intestine: Formalin-Fixed, Paraffin-Embedded (FFPE)
Antibody (1 µg/ml) staining of human spleen lysate (35 µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
Human Skeletal muscle; Skeletal muscle; ACSL5 antibody - C-terminal region (ARP47232_P050) in Human Skeletal muscle cells using Immunohistochemistry
Human Placenta; WB Suggested Anti-ACSL5 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:312500. Positive Control: Human Placenta; ACSL5 antibody - C-terminal region (ARP47232_P050) in Human Placenta cells using Western Blot
TA303108 (1µg/ml) staining of human spleen lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
Western blot analysis of extracts of mouse brain tissue lines, using ACSL5 antibody.
WB Suggested Anti-ACSL5 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 312500; Positive Control: Human Placenta
Skeletal muscle
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA303108 | ACSL5 antibody |
||||||
| Goat Polyclonal Antibody against ACSL5 | |||||||
 |
Goat | Aff - Purified | Hu | WB |
0.1 mg /
€360.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA332397 | ACSL5 antibody |
||||||
| Rabbit anti-ACSL5 Polyclonal Antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms, Rt | WB |
0.1 mg /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| AP08976PU-N | ACSL5 (727-739) antibody |
||||||
 |
Goat | Aff - Purified | Hu, Mky | E, P, WB |
50 µg /
€425.00
|
||
| OriGene Technologies GmbH | |||||||
 +1 additional image |
|||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP313380 | ACSL5 (transcript variant 2) |
||||
| Recombinant protein of human acyl-CoA synthetase long-chain family member 5 (ACSL5), transcript variant 2 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
| TP318932 | ACSL5 (transcript variant 3) |
||||
| Recombinant protein of human acyl-CoA synthetase long-chain family member 5 (ACSL5), transcript variant 3 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY404321 | ACSL5 overexpression lysate |
|
 |
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. | ||
| LY404322 | ACSL5 overexpression lysate |
|
|
0.1 mg /
€495.00
|
|
| OriGene Technologies, Inc. | ||
| LY414108 | ACSL5 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. |
Mouse Lenti ORF Particles
| Catalog No. | ||
|---|---|---|
| MR210022L2V | Lenti ORF particles, Acsl5 (GFP-tagged) - Mouse acyl-CoA synthetase long-chain family member 5 (Acsl5), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,440.00
|
|
| OriGene Technologies, Inc. | ||
| MR210022L1V | Lenti ORF particles, Acsl5 (Myc-DDK-tagged) - Mouse acyl-CoA synthetase long-chain family member 5 (Acsl5), 200 uL, >10^7 TU/mL |
|
|
200 µl /
€1,290.00
|
|
| OriGene Technologies, Inc. | ||